I wonder if you could overlay the share price performance with the revenue growth (to show how the share price has moved in completely the opposite direction to the significant improvement in fundamentals), or is mixing the FA and the TA like that frowned upon by the chartists? Maybe even identify all the significant milestones on the chart, and how the share price has continued to fail to recognise the significance of them...
Oh well, I have always found that share prices never remain detached to the fundamentals forever! A bit less than 3 weeks until the AGM, let's see if EYE can score a massive 2RT deal before then to put a very big smile on the faces of all in attendance, or of course, report incredible sales performance for iTrack Advance. I would like to hear how China is going as well, as that seems to be a significant opportunity for the company based on the spectacular revenue growth of 318% recorded in that market over the course of FY23. Come on Nova Eye, give us something "eye watering" before the end of the year
(20min delay)